Agenda for 5 September International Pediatric-COVID-19 Collaborative Webinar 17:30-18:30 EDT/New York; 21:30-22:30--UTC
17:30-17:40 EDT/New York---Adaptive Point Prevalence International Survey
Katri Typpo, MD-Division Chief, Critical Care Medicine and Associate Professor, University of Arizona College of Medicine-Tucson
17:40-18:00 EDT/New York-Epidemiology of MIS-C-Q&A
Mike Levin, MD-Professor of Paediatrics & International Child Health at Imperial College
18:00-18:20 EDT/New York---Therapy for MIS-C-Q&A with International Panel of Experts
Edward M. Behrens, MD-Chief of the Division of Rheumatology, Children's Hospital of Philadelphia; Associate Professor of Pediatrics, Perelman School of Medicine, University of Pennsylvania
Kevin Friedman, MD-Pediatric Cardiology, Boston Children's Hospital; Associate Professor of Pediatrics, Harvard Medical School
Lauren A. Henderson, MD, MMSc-Pediatric Rheumatology, Boston Children's Hospital; Assistant Professor of Pediatrics, Harvard Medical School
Jay Mehta, MD, Ms-Pediatric Rheumatology, Children's Hospital of Philadelphia; Associate Professor of Clinical Pediatrics, Perelman School of Medicine, University of Pennsylvania
Rae S. M. Yeung, MD, PhD-Rheumatology, The Hospital for Sick Children; Senior Scientist in Cell Biology, The Research Institute; Professor of Pediatrics, University of Toronto
18:20-18:30 EDT/New York---Personal Vignettes-Question for the Audience via Chat
Vinay Nadkarni, MD-Professor of Anesthesiology, Critical Care, and Pediatrics; Children's Hospital of Philadelphia, the Perelman School of Medicine, University of Pennsylvania
Next webinars:
Saturday-17:30-18:30 New York / 21:30-22:30 UTC
5 September
3 October
7 November
5 December
To join the distribution list contact: Susan Kourtis: susan.kourtis@childrens.harvard.edu for further information
Please see below Funding Opportunity Announcement and share widely: https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-20-023.html
Emergency Awards (RFA OD-20-023): RADx-rad Predicting Viral-Associated Inflammatory Disease Severity in Children with Laboratory Diagnostics and Artificial Intelligence (PreVAIL kIds) (R61/R33 Clinical Trial Optional)
RFA OD-20-023 will support research on laboratory diagnostics integrated with digital health technologies and AI-based algorithms to rapidly diagnose and characterize SARS-CoV-2 associated illness in children and predict disease severity, including MIS-C. Please also note the companion FOA (RFA OD-20-019) for the Data Coordinating Center linked in the announcement.
Key Dates:
Letter of Intent Due Date: August 30, 2020
Application Due Date: September 30, 2020 – (No Late Applications Accepted)
Scientific Merit Review: October 2020
Earliest Start Date: : November 2020
Expiration Date: October 1, 2020